WO2004107875A1 - Composition emulsionnable contenant des phospholipides - Google Patents
Composition emulsionnable contenant des phospholipides Download PDFInfo
- Publication number
- WO2004107875A1 WO2004107875A1 PCT/JP2004/008180 JP2004008180W WO2004107875A1 WO 2004107875 A1 WO2004107875 A1 WO 2004107875A1 JP 2004008180 W JP2004008180 W JP 2004008180W WO 2004107875 A1 WO2004107875 A1 WO 2004107875A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- phospholipid
- weight
- composition
- contained
- phosphatidylserine
- Prior art date
Links
- 150000003904 phospholipids Chemical class 0.000 title claims abstract description 87
- 239000000203 mixture Substances 0.000 title claims abstract description 64
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims abstract description 18
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims abstract description 18
- 230000002378 acidificating effect Effects 0.000 claims abstract description 12
- 230000007935 neutral effect Effects 0.000 claims abstract description 11
- 235000013305 food Nutrition 0.000 claims description 31
- 230000001804 emulsifying effect Effects 0.000 claims description 29
- 150000003905 phosphatidylinositols Chemical class 0.000 claims description 16
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 claims description 8
- 239000000463 material Substances 0.000 description 26
- 239000000839 emulsion Substances 0.000 description 19
- 238000000034 method Methods 0.000 description 18
- 239000000787 lecithin Substances 0.000 description 15
- 229940067606 lecithin Drugs 0.000 description 15
- 239000003925 fat Substances 0.000 description 13
- 235000019197 fats Nutrition 0.000 description 13
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 11
- -1 Lipid II Phospholipid Chemical class 0.000 description 11
- 235000010445 lecithin Nutrition 0.000 description 11
- 239000003921 oil Substances 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000000047 product Substances 0.000 description 10
- 241000251468 Actinopterygii Species 0.000 description 9
- 241000287828 Gallus gallus Species 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 9
- 239000000306 component Substances 0.000 description 9
- 238000004945 emulsification Methods 0.000 description 9
- 239000003995 emulsifying agent Substances 0.000 description 9
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 8
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 8
- 235000014113 dietary fatty acids Nutrition 0.000 description 8
- 229930195729 fatty acid Natural products 0.000 description 8
- 239000000194 fatty acid Substances 0.000 description 8
- 229940083466 soybean lecithin Drugs 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 239000003549 soybean oil Substances 0.000 description 7
- 235000012424 soybean oil Nutrition 0.000 description 7
- 235000013372 meat Nutrition 0.000 description 6
- 244000068988 Glycine max Species 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 125000001095 phosphatidyl group Chemical group 0.000 description 5
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 5
- 238000013112 stability test Methods 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 3
- 235000017060 Arachis glabrata Nutrition 0.000 description 3
- 244000105624 Arachis hypogaea Species 0.000 description 3
- 235000010777 Arachis hypogaea Nutrition 0.000 description 3
- 235000018262 Arachis monticola Nutrition 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- 240000005979 Hordeum vulgare Species 0.000 description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 241001494479 Pecora Species 0.000 description 3
- 102000011420 Phospholipase D Human genes 0.000 description 3
- 108090000553 Phospholipase D Proteins 0.000 description 3
- 235000004443 Ricinus communis Nutrition 0.000 description 3
- 241000282898 Sus scrofa Species 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 description 3
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 235000012343 cottonseed oil Nutrition 0.000 description 3
- 210000002969 egg yolk Anatomy 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 235000020232 peanut Nutrition 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 239000008347 soybean phospholipid Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 238000006276 transfer reaction Methods 0.000 description 3
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000015895 biscuits Nutrition 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000013345 egg yolk Nutrition 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 239000008268 mayonnaise Substances 0.000 description 2
- 235000010746 mayonnaise Nutrition 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229960001153 serine Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000005428 food component Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003906 phosphoinositides Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 235000013324 preserved food Nutrition 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
- C09K23/14—Derivatives of phosphoric acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J7/00—Phosphatide compositions for foodstuffs, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/10—Foods or foodstuffs containing additives; Preparation or treatment thereof containing emulsifiers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to a phospholipid-containing emulsifiable composition containing phosphatidylserine and having excellent emulsifiability.
- PS Phosphatidylserine
- Ps in phospholipids a natural component, does not exceed a few percent in plants and more than 20% in the brains of animals, which are considered the most common. For this reason, it is difficult to ingest from the diet enough PS to exert physiological functions, and it is a practical method to supplementally ingest materials containing high concentrations of PS.
- Material containing high concentration of PS As a method for obtaining the raw material, there are a method of fractionating phospholipids extracted from natural products, and a method of producing phosphatidyl group by a phosphatidyl group transfer reaction from other compounds to serine.
- PS there are various methods for ingesting PS, such as intravenous administration and oral administration.
- intravenous administration for example, mixing with other excipients such as phospholipids, sugars, and proteins will improve the ease of handling and storage.
- Formulations added to improved capsules and granules are used.
- PS since there is no problem in terms of safety, PS may be added to foods and drinks taken daily.
- PS or a phospholipid-containing material containing a high concentration of PS has low solubility in fats and oils (such as soybean oil), and even if it is dissolved by applying heat, it hardens when the temperature drops, and foods This is not preferable in producing In addition, its low solubility in water makes it difficult to handle. For this reason, PS is mainly used as a capsule or granular preparation (see Shinsei Kagaku Kenkyusho 4, 1 Lipid II Phospholipid, edited by The Biochemical Society of Japan, p. 549, Tokyo Kagaku Dojin (1991)).
- PS is useful as a material for health foods and the like, but its application range is limited due to its low solubility in oils and fats and low water solubility.
- PS is emulsified with an emulsifier or a surfactant to be contained in food.
- food additives that can be used in foods, pharmaceuticals, etc., lecithin, sucrose fatty acid esters, glycerin fatty acid esters, sorbitanic acid esters, propylene glycol fatty acid esters, and the like are widely used.
- a lecithin is preferred from the viewpoint of being a lipid and a natural emulsifier, but relatively mild foods such as fatty acid monoglyceride, sucrose fatty acid ester, and polyglycerin fatty acid ester are preferable.
- the emulsion stability is inferior to that of the additive surfactant.
- PG phosphatidylglycerol
- An object of the present invention is to solve the above problems, and an object of the present invention is to provide an emulsifying composition capable of effectively emulsifying PS. Another object of the present invention is to provide an emulsifiable yarn composition capable of blending Ps in a food or drink without using a commonly used emulsifier, surfactant or the like, and the composition. It is to provide a food containing.
- PI phosphatidylinositol
- the first phospholipid-containing emulsifiable composition of the present invention contains phosphatidylserine, phosphatidylinositol, and neutral phospholipid, and the composition contains, based on the weight of the entire phospholipid, phosphatidylserine 5-8 5 by weight 0/0, and phosphatidylinositol are containing organic at a rate of 2.5 to 3 0 wt 0/0, and with respect to the neutral phospholipid 1 part by weight, the phosphatidylserine And acidic phospholipids including phosphatidylinositol in a total amount of 1.0 to 7.4 parts by weight.
- the second phospholipid-containing emulsifiable composition of the present invention contains phosphatidylserine, phosphatidylinositol, and phosphatidic acid, and the composition contains the phosphatidylserine based on the weight of the entire phospholipid.
- Is 5 ⁇ 8 5 weight 0/0 and phosphatidylinositol 2,. 5-3 0 is in a weight percent proportion, and when the weight of total phospholipid, total weight of phosphatidyl phosphate Contact Yopi phosphatidylinositol Ranges from more than 2.5% to 36% by weight.
- the present invention includes a food containing the first or second phospholipid-containing emulsifiable composition.
- the first emulsifiable phospholipid-containing composition of the present invention contains acidic phospholipids of PS and PI, and a neutral phospholipid, and optionally contains acidic phospholipids other than PS and PI.
- the second phospholipid-containing emulsifiable composition of the present invention contains PS, PI, and phosphatidic acid (hereinafter, may be abbreviated as PA), and optionally contains other than PS, PI, and PA. Contains acidic phospholipids, neutral phospholipids, etc.
- these first and second emulsifiable compositions may contain general-purpose emulsifiers, additives and the like.
- the origin of the PS contained in the first and second compositions of the present invention is not particularly limited.
- PS derived from plants such as soybean, wheat, barley, corn, castor, rape, peanut, cottonseed, and rice; PS derived from yolk; PS derived from animal brain such as cow, pig, sheep, chicken, fish, etc. PS; PS derived from microorganisms such as yeast; and PS derived from animal meat or offal such as chicken, chicken offal, fish body, fish meat and the like can be used.
- the Folch method see J. Folch, I. Ascoli, M. Lees, JA Meath, FN LeBaron, J. Biol.
- PS is a compound having a phosphatidyl group, for example, a phosphatidyl group transfer reaction between phosphatidylcholine and L-serine, or It can be produced by other organic synthesis methods.
- PS is contained in a proportion of 5 to 85% by weight, preferably 7 to 30% by weight, based on the total weight of the phospholipid contained in the composition of the present invention. If the amount is less than 5% by weight or exceeds 85% by weight, problems may occur in terms of a decrease in emulsifying power and a decrease in emulsion stability.
- the purity of PS used is not particularly limited, and it is preferable to include the PS so that the final phospholipid composition in the composition falls within a desired range. Therefore, it is possible to use any of the purified PS, the above extract, the fractionated concentrate of the extract, and the product obtained by synthesis.
- PI contained in the composition of the present invention is a kind of acidic phospholipid and usually widely exists mainly as a component of cell membranes of animals, plants, microorganisms and the like.
- the content is high in plant seeds such as soybean, rapeseed and linseed, and yeast.
- PI is a substance that is involved in the signaling of cells in vivo and is attracting attention in physiology along with its lysate (J.EA.Bleasdale, et al (eds), Inositol and Phosphoinositides, Humana Press, 1985) See).
- J.EA.Bleasdale, et al (eds), Inositol and Phosphoinositides, Humana Press, 1985 See
- it has been reported that as a component of oils and fats for heating cooking, it shows excellent action in flavor and release properties (Japanese Patent Application Laid-Open Nos. 4-330253 and 5-116680). No.
- the origin of the PI used in the present invention is not particularly limited.
- PI derived from plants such as soybean, wheat, barley, corn, castor, rape, peanut, cottonseed, and rice; PI derived from egg yolk; PI derived from animal brain such as cow, pig, sheep, chicken, fish, etc.
- Any of PI derived from microorganisms such as yeast; and PI derived from animal meat or offal such as chicken, chicken offal, fish body, fish meat and the like. It can be obtained by concentrating extracts obtained from these raw materials by, for example, the Folch method or the Bligh-Dyer method.
- the cell thread is homogenized by a conventional method, and a lipid component is obtained by a method such as fractionation or extraction.
- a lipid component is obtained by a method such as fractionation or extraction.
- an adsorbent such as silica gel or a liquefied gas under supercritical conditions
- the mixed phospholipids can be concentrated and purified to the purity used in the present invention through the state of the mixed phospholipid.
- PI can be produced by an organic synthesis method.
- PI is contained in a proportion of 2.5 to 30% by weight based on the total weight of the phospholipid contained in the composition of the present invention. If the amount is less than 2.5% by weight or exceeds 30% by weight, problems may occur in terms of a decrease in emulsifying power and a decrease in emulsion stability.
- the purity of the PI used is not particularly limited, and it is preferable to include the PI so that the final phospholipid composition in the composition falls within a desired range.
- Neutral phospholipids that can be contained in the composition of the present invention include phosphatidylcholine (hereinafter sometimes abbreviated as PC), phosphatidylethanolamine (hereinafter sometimes abbreviated as PE), lysolecithin (hereinafter, abbreviated as PE). (Sometimes abbreviated as LPL; lysolecithin may be an acidic phospholipid).
- the first phospholipid-containing emulsifying composition of the present invention preferably contains 1.0 to 7.4 parts by weight of an acidic phospholipid with respect to 1 part by weight of the neutral phospholipid. If the amount of the acidic phospholipid is less than 1.0 part by weight or exceeds 7.4 parts by weight, inconvenience may occur in terms of a reduction in emulsifying power and a reduction in emulsification stability. is there.
- lysolecithin LPL
- its content is 5% by weight or less from the viewpoint of preventing a decrease in emulsifying power and emulsion stability.
- PA which can be contained in the composition of the present invention is an acidic phospholipid like PS and PI described above.
- the origin of this PA is not particularly limited.
- PA from plants such as soybean, wheat, barley, corn, castor, rape, peanut, cottonseed, and rice;
- PA from egg yolk, PA from animal brain such as cow, pig, sheep, chicken, fish, and yeast; yeast.
- Microorganisms such as PA; and animals such as chicken, chicken offal, fish, and fish meat Either meat or offal-derived PA can be used, and it can be obtained by concentrating an extract obtained from these raw materials by, for example, the above-mentioned Folch method or Bligh-Dyer method.
- PA may be produced by a hydrolysis reaction using phospholipase D (PLD), or may be obtained by fractionating and concentrating them, or may be produced by an organic synthesis method.
- PLD phospholipase D
- the PA When PA is contained in the composition, the PA is preferably contained in a proportion of 1.0 to 15.0% by weight based on the total weight of the phospholipid. By containing PA, the emulsifying power can be further increased. Further, in this composition, the total weight of PA and PI preferably ranges from more than 2.5% to 36% by weight, more preferably 19% by weight, based on the total weight of the phospholipid. ⁇ 36% by weight. If the total weight is less than 2.5% by weight, or if it exceeds 36% by weight, inconvenience may occur in terms of a decrease in emulsifying power and emulsion stability.
- the purity of the PA used is not particularly limited, and it is preferable that the final phospholipid thread in the composition is contained in a desired range.
- Examples of the general-purpose emulsifier contained in the phospholipid-containing emulsifying composition of the present invention include sucrose fatty acid esters.
- the phospholipid-containing emulsifiable composition of the present invention is suitably used for emulsification of fats and oils, particularly for producing emulsified foods containing a large amount of fats and oils.
- the type of the fat is not particularly limited, and may be any fat or oil that is liquid at normal temperature.
- vegetable oils such as soybean oil, corn oil, safflower oil, olive oil, and peanut oil; animal oils such as fish oil; oils such as medium-chain fatty acid triglycerides produced by ester synthesis using enzymes. .
- the method for emulsifying fats and oils using the phospholipid-containing emulsifiable composition of the present invention is not particularly limited, and it is not necessary to employ a special emulsification method.
- a conventional emulsifier consisting of soybean lecithin, which is a phospholipid mixture
- Fats and oils can be emulsified.
- each component of the composition of the present invention is added to and dissolved in fats and oils to be emulsified, and mixed with water or an aqueous solution of another material to emulsify.
- a water-soluble emulsifier preferably an emulsifier having an HLB power of S5 or more; for example, a sucrose fatty acid ester
- emulsification becomes easy.
- a homogenizer, ultrasonic waves, or the like can be used for mixing, and the mixture can be heated to a temperature of about 50 ° C. or higher during the treatment.
- an emulsion is prepared in advance by mixing each component of the composition with a fat (liquid fat) to be contained in the food. May be mixed with other components of the food, or emulsification may be directly performed using each component of the composition and a component to be contained in the food.
- Foods containing the phospholipid-containing emulsifiable composition of the present invention are not particularly limited, but are preferably dairy products such as ice cream, cheese, powdered milk, pudding, and taroim; breads, cakes, and biscuits. And flour-containing foods such as coconut and ;; margarine, mayonnaise, chocolate, fried (for example, pork), and tempura-containing foods; and beverages such as canned coffee, soy milk, milk, and cocoa.
- the shape of the food product is not particularly limited.
- the food product can be used as retort food (food obtained by pressurizing plastic bag-packed food or canned food).
- this food can be used as a health food (a food containing ingredients for promoting health, such as peptides, oligosaccharides, DHA, and aloe).
- the content of the composition of the present invention in the food varies depending on the type of food, processing conditions, and the like, but is, for example, 0.001 to 5% by weight, and preferably 0.01 to 2% by weight.
- the content of fats and oils in foods is not particularly limited, but is usually 4 to 90% by weight, preferably 4 to 75% by weight, and the water content is usually 9 to 95% by weight, preferably 25 to 25% by weight. ⁇ 95% by weight. Since the first and second phospholipid-containing emulsifying compositions of the present invention both have a specific composition containing PS and PI, they have excellent emulsifying ability and emulsifying stability. ? 3 hours?
- a stable emulsified state can be obtained by using the composition of the present invention having a specific composition having these in combination. Therefore, a stable emulsified food can be obtained by using this, and daily ingestion of PS becomes very easy.
- Phosphorus is converted from commercially available soy lecithin (product name: BHN PS-20P, manufactured by B.A.C.H.) by the Bligh-Dyer method (see EG Bligh, WJ Dyer, Can. J. Biochem. Physiol., 37, 911 (1959)). The lipid was extracted.
- Commercially available soybean lecithin (Product name: SLP-PC70, manufactured by Tsuru-Lecithin Industry Co., Ltd., Product name: SLP-PI powder-1, manufactured by Tsuru-Lecithin Industry Co., Ltd .; Product name: SLP White, Tsuru-Lecithin Industry Co., Ltd. Was used without extraction.
- soybean lecithin product name: SLP-PC70, made by Tsuruichi Lecithin Industry Co., Ltd.
- PLD phospholipidase D
- the extracted phospholipid, soybean lecithin (SLP-PC70), and hydrolyzed lecithin were appropriately mixed to obtain a phospholipid-containing emulsifiable material having the composition shown in Table 1.
- the ratio of each phospholipid in Table 1 is the content (% by weight) based on the total weight of the phospholipid in the obtained emulsifiable material.
- a phospholipid, a commercially available soybean lecithin, and a hydrolyzed lecithin obtained by extraction in the same manner as in Example 1 were prepared, and these were appropriately mixed to obtain a phospholipid-containing emulsifying material having the composition shown in Table 1. .
- the stability of the emulsion containing these was evaluated in the same manner as in Example 1. The results are shown in Table 1. table 1
- PS phosphatidylserine
- PC phosphatidylcholine
- ⁇ phosphatidylinositol PE: phosphatidylethanolamine
- Example 3 1 g of the phospholipid-containing emulsifiable material obtained in Example 3 was mixed with soybean oil and water in the amounts shown in Table 2, and water was added as necessary to obtain a mixture having a final volume of 100 mL. Was. This was emulsified at room temperature for 5 minutes using a homogenizer (manufactured by Nippon Seiki Co., Ltd.) to obtain an emulsion. This emulsion was subjected to the same stability test as in Example 1. The results are shown in Table 2. The criteria for determining stability are the same as those in the first embodiment.
- the phospholipid-containing emulsifiable material was 1% by weight / volume, and the fat and oil was 4 to 89 volumes. It can be seen that the emulsion containing / 0 and water in a proportion of 95 to 10% by volume exhibits excellent emulsification stability. Comparative Examples 1-2
- a phospholipid, a commercially available soybean lecithin, and a hydrolyzed lecithin obtained by extraction in the same manner as in Example 1 were prepared, and these were appropriately mixed to obtain a phospholipid-containing curable material having the composition shown in Table 3.
- the proportion of each phospholipid in Table 3 is the content (% by weight) based on the total weight of the phospholipid in the obtained emulsifiable material. 1 g of this phospholipid-containing emulsifying material is added to 74 m1 of soybean oil and 25 m1 of water and emulsified at room temperature for 5 minutes using a homogenizer (manufactured by Nippon Seiki Co., Ltd.). A liquid was obtained. The obtained emulsion was subjected to a stability test in the same manner as in Example 1. The results are shown in Table 3. The criteria for determining stability are the same as in the first embodiment. Table 3
- PS phosphatidylserine
- PC phosphatidylcholine
- PI phosphatidylinositol PE: phosphatidylethanolamine
- PA phosphatidic acid
- Comparative Example 3 A phospholipid-containing emulsifying material (soy lecithin) consisting only of PS was prepared, and 1 g of this emulsifying material was mixed with the amount of soybean oil and water shown in Table 4 and homogenized at room temperature for 5 minutes (Japan). The mixture was emulsified by using Seiki Co., Ltd.) to obtain an emulsion. This emulsion was subjected to a stability test in the same manner as in Example 5. The results are shown in Table 4. The criteria for determining stability are the same as in the first embodiment. Table 4
- soy lecithin product name: SLP—white, vinegar lecithin industrial Co., Ltd.
- soybean lecithin product name: SLP—PI powder, vinegar As a material for Comparative Example 6
- soybean lysolecithin product name: SLP—white lyso, Tsuru-Lecithin Industry Co., Ltd.
- a phosphatidyl glycerol preparation was obtained by performing a phosphatidyl group transfer reaction in the presence of lyserol pLD, and this was used as a material for Comparative Example 7 .
- Table 5 shows the composition of these materials. The proportion of each phospholipid in Table 5 is the content (% by weight) based on the weight of the total phospholipids in each material. Using these materials as phospholipid-containing emulsifiable materials, emulsions were prepared in the same manner as in Example 1, and the same stability test was performed. Table 5 shows the results. The criteria for determining stability are the same as in the first embodiment.
- PS phosphatidylserine
- PE phosphatidylethanolamine
- PI phosphatidylinositol LPL: lysolecithin
- PA phosphatidic acid
- PG phosphatidylglycerol
- PC phosphatidylcholine
- a phospholipid-containing emulsifying composition containing phosphatidylserine, phosphatidylinositol, and a neutral phospholipid or phosphatidic acid at a predetermined ratio and having excellent emulsifying function and high stability. Things are obtained.
- the composition is used in various forms of food, including mayonnaise, cream, bread, biscuits, beverages, and seasonings.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- General Preparation And Processing Of Foods (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003162870 | 2003-06-06 | ||
JP2003-162870 | 2003-06-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004107875A1 true WO2004107875A1 (fr) | 2004-12-16 |
Family
ID=33508680
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/008180 WO2004107875A1 (fr) | 2003-06-06 | 2004-06-04 | Composition emulsionnable contenant des phospholipides |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2004107875A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008120214A2 (fr) * | 2007-04-01 | 2008-10-09 | Enzymotec Ltd. | Compositions contenant le phosphatidylsérine dans le traitement de conditions associées au diabète |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09165A (ja) * | 1995-06-19 | 1997-01-07 | Kao Corp | 酸性リン脂質の濃縮法 |
JP2002051794A (ja) * | 2000-08-09 | 2002-02-19 | Yakult Honsha Co Ltd | リン脂質の製造法 |
JP2003095953A (ja) * | 2001-09-25 | 2003-04-03 | Nof Corp | ホスファチジルセリン含有組成物、製造方法および用途 |
-
2004
- 2004-06-04 WO PCT/JP2004/008180 patent/WO2004107875A1/fr not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09165A (ja) * | 1995-06-19 | 1997-01-07 | Kao Corp | 酸性リン脂質の濃縮法 |
JP2002051794A (ja) * | 2000-08-09 | 2002-02-19 | Yakult Honsha Co Ltd | リン脂質の製造法 |
JP2003095953A (ja) * | 2001-09-25 | 2003-04-03 | Nof Corp | ホスファチジルセリン含有組成物、製造方法および用途 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008120214A2 (fr) * | 2007-04-01 | 2008-10-09 | Enzymotec Ltd. | Compositions contenant le phosphatidylsérine dans le traitement de conditions associées au diabète |
WO2008120214A3 (fr) * | 2007-04-01 | 2008-12-31 | Enzymotec Ltd | Compositions contenant le phosphatidylsérine dans le traitement de conditions associées au diabète |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7056949B2 (en) | Oil/fat composition | |
Schneider | Phospholipids | |
KR101144834B1 (ko) | 인지질과 장쇄 고도 불포화 지방산 공급 화합물을 함유하는 유지 조성물, 및 이를 이용한 식품 | |
US20100197785A1 (en) | Omega-3 fatty acid fortified composition | |
JP2006075164A (ja) | 不飽和脂肪酸及びそのエステルを含むエマルション | |
NO20052498L (no) | Marine lipidforbindelser | |
WO2005073355A1 (fr) | Composition ferrique | |
EP0253429B1 (fr) | Composés contenant des phosphatides et procédé pour leur préparation | |
JPS647754B2 (fr) | ||
JP4054524B2 (ja) | 酸性水中油型乳化組成物 | |
WO1998039977A1 (fr) | Aliment contenant une matiere grasse ou de l'huile | |
JP5094094B2 (ja) | 食後血中インスリン上昇抑制剤 | |
JP5739180B2 (ja) | インスリン分泌促進用油脂組成物 | |
US20120282368A1 (en) | Amphiphilic sterol/fat-based particles | |
WO2004107875A1 (fr) | Composition emulsionnable contenant des phospholipides | |
JP4969989B2 (ja) | リン脂質組成物およびこれを含有する食品組成物、医薬品組成物、並びにその製造方法 | |
JP3247206B2 (ja) | ミルク組成物 | |
JP2000300186A (ja) | 代謝改善剤 | |
JP5167199B2 (ja) | 乳化液状栄養食 | |
JP4139557B2 (ja) | 酸性水中油型乳化組成物 | |
JP6418960B2 (ja) | 粉末素材 | |
JP4185547B2 (ja) | 酸性水中油型乳化組成物 | |
Phosphatidylcholine et al. | Michael Schneider | |
EP0375785B1 (fr) | Composition de lipides a fiabilite suffisante et a forte activite de surface | |
Schneider | I. TERMINOLOGY |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |